Gerard J. Criner, MD, FACP, FACCP, discusses the AIRFLOW-3 study which evaluates the efficacy of targeted lung denervation for patients with COPD.
Related Presenters
Gerard Criner, MD, FACP, FACCP
Director, Temple Lung Center
Dr. Criner is an internationally renowned pulmonologist who specializes in Pulmonary Disease, with a special focus on Chronic Obstructive Lung Disease (COPD), Transplant Medicine-Lung and Airway Disorders.
